down arrow

Nippon Chemiphar Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3701600003
JPY
1,525.00
-23 (-1.49%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fuji Pharma Co., Ltd.
Koa Shoji Holdings Co., Ltd.
Taiko Pharmaceutical Co., Ltd.
Nippon Chemiphar Co., Ltd.
BrightPath Biotherapeutics Co., Ltd.
Noile-Immune Biotech, Inc.
Healios KK
Fuso Pharmaceutical Industries Ltd.
RaQualia Pharma, Inc.
SymBio Pharmaceuticals Ltd.
CanBas Co., Ltd.
Why is Nippon Chemiphar Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.68%
  • The company has been able to generate a Return on Capital Employed (avg) of 1.68% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.89
  • Poor long term growth as Net Sales has grown by an annual rate of 0.51% and Operating profit at 10.71% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.89
  • The company has been able to generate a Return on Equity (avg) of 2.50% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 0.51% and Operating profit at 10.71% over the last 5 years
4
Negative results in Jun 25
  • INTEREST(HY) At JPY 106 MM has Grown at 21.84%
  • CASH AND EQV(HY) Lowest at JPY 16,709 MM
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nippon Chemiphar Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nippon Chemiphar Co., Ltd.
0.66%
-0.14
18.16%
Japan Nikkei 225
28.54%
1.11
25.75%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0.51%
EBIT Growth (5y)
10.71%
EBIT to Interest (avg)
1.89
Debt to EBITDA (avg)
4.02
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
0.88
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
61.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.68%
ROE (avg)
2.50%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.32
EV to EBIT
26.59
EV to EBITDA
8.14
EV to Capital Employed
0.56
EV to Sales
0.50
PEG Ratio
0.03
Dividend Yield
0.03%
ROCE (Latest)
2.09%
ROE (Latest)
2.68%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
ROCE(HY)

Highest at 2.12%

PRE-TAX PROFIT(Q)

At JPY 305 MM has Grown at 105.04%

RAW MATERIAL COST(Y)

Fallen by -5.68% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 2.84%

NET PROFIT(Q)

At JPY 227 MM has Grown at 76.73%

-9What is not working for the Company
INTEREST(HY)

At JPY 106 MM has Grown at 21.84%

CASH AND EQV(HY)

Lowest at JPY 16,709 MM

Here's what is working for Nippon Chemiphar Co., Ltd.
Pre-Tax Profit
At JPY 305 MM has Grown at 105.04%
over average net sales of the previous four periods of JPY 148.75 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit
At JPY 227 MM has Grown at 76.73%
over average net sales of the previous four periods of JPY 128.45 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (JPY MM)

Debtors Turnover Ratio
Highest at 2.84%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -5.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nippon Chemiphar Co., Ltd.
Interest
At JPY 106 MM has Grown at 21.84%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv
Lowest at JPY 16,709 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."